Ice formation, cryoconcentration, pH shifts, and repeated freeze-thaw cycles can damage peptide integrity or create aggregation
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ 63%, compared with 34% of those taking a placebo, researchers reported April 30 in the New England Journal of Medicine
The determining factor is dose, not brand name
The rate of carnitine excretion is not a useful indicator of carnitine status because it can vary with dietary carnitine intake and other physiologic parameters
Add 10-20% buffer for potential delays, degradation, or protocol adjustments
What should I do if I have severe gastrointestinal side effects from GLP-1 medications